Bank Of Montreal Anavex Life Sciences Corp. Transaction History
Bank Of Montreal
- $214 Billion
- Q3 2024
A detailed history of Bank Of Montreal transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Bank Of Montreal holds 19,880 shares of AVXL stock, worth $184,287. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,880
Previous 15,463
28.56%
Holding current value
$184,287
Previous $65,000
72.31%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding AVXL
# of Institutions
164Shares Held
27.5MCall Options Held
515KPut Options Held
838K-
Black Rock Inc. New York, NY6.39MShares$59.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.74MShares$43.9 Million0.0% of portfolio
-
State Street Corp Boston, MA3.07MShares$28.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.88MShares$17.5 Million0.0% of portfolio
-
Nwam LLC Mercer Island, WA910KShares$8.44 Million0.32% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $723M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...